Attached files
| file | filename |
|---|---|
| 10-K - BOSTON THERAPEUTICS, INC. 10-K - Boston Therapeutics, Inc. | bostontherapeutics10k.htm |
| EX-31.1 - EXHIBIT 31.1 - Boston Therapeutics, Inc. | exh31_1.htm |
| EX-32.1 - EXHIBIT 32.1 - Boston Therapeutics, Inc. | exh32_1.htm |
| EX-32.2 - EXHIBIT 32.2 - Boston Therapeutics, Inc. | exh32_2.htm |
| EX-31.2 - EXHIBIT 31.2 - Boston Therapeutics, Inc. | exh31_2.htm |
| EX-23.1 - EXHIBIT 23.1 - Boston Therapeutics, Inc. | exh23_1.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statements (No. 333-185355, 333-177171 and 333-195341) on Form S-8 of Boston Therapeutics, Inc. of our report dated March 27, 2015, relating to our audit of the financial statements as of and for the year ended December 31, 2014, which appear in this Annual Report on Form 10-K of Boston Therapeutics, Inc. for the year ended December 31, 2015.
/s/ RSM US LLP
Boston, Massachusetts
March 30, 2016